EX-99.1 2 tm2114776d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

SYNAPTOGENIX, INC.

BALANCE SHEETS

 

(Unaudited) 

 

   As Filed   Offering   Pro forma as of 
   December 31,   Entries   December 31, 
   2020   January 2021   2020 
ASSETS               
CURRENT ASSETS               
Cash and cash equivalents  $5,795,055   $12,589,667   $18,384,722 
Grant receivable   127,445    -    127,445 
Prepaid expenses and other current assets   806,289    -    806,289 
                
TOTAL CURRENT ASSETS   6,728,789    12,589,667    19,318,456 
                
Fixed assets, net of accumulated depreciation   22,212    -    22,212 
                
TOTAL ASSETS  $6,751,001   $12,589,667   $19,340,668 
                
                
LIABILITIES AND SHAREHOLDERS' EQUITY               
CURRENT LIABILITIES               
Accounts payable  $1,260,335   $-   $1,260,335 
Accrued expenses   352,154    -    352,154 
                
TOTAL CURRENT LIABILITIES   1,612,489    -    1,612,489 
                
Commitments and contingencies               
                
SHAREHOLDERS' EQUITY               
Preferred stock - 1,000,000 shares authorized as of December 31, 2020, $0.0001 par value;               
0 shares issued and outstanding as of December 31, 2020               
Common stock - 150,000,000 shares authorized as of December 31, 2020, $0.0001 par value;   -    -    - 
5,030,316 shares issued and outstanding as of December 31, 2020               
14,032,516 pro forma shares issued and outstanding as of December 31, 2020.   503    900    1,403 
Additional paid-in capital   6,668,482    12,588,767    19,257,249 
Accumulated deficit   (1,530,473)   -    (1,530,473)
                
TOTAL SHAREHOLDERS' EQUITY   5,138,512    12,589,667    17,728,179 
                
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  $6,751,001   $12,589,667   $19,340,668